Fig. 6From: Safety and efficacy of anti-inflammatory therapy in patients with coronary artery disease: a systematic review and meta-analysisSubgroup analysis of targeting the central IL-6 inflammatory signaling pathway drugs and PLA2 inhibitorsBack to article page